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Sun Wook Cho5,7* & Jin Young Kwak3,7*
To compare the diagnostic performances of physicians and a deep convolutional neural network (CNN) 
predicting malignancy with ultrasonography images of thyroid nodules with atypia of undetermined 
significance (AUS)/follicular lesion of undetermined significance (FLUS) results on fine‑needle 
aspiration (FNA). This study included 202 patients with 202 nodules ≥ 1 cm AUS/FLUS on FNA, 
and underwent surgery in one of 3 different institutions. Diagnostic performances were compared 
between 8 physicians (4 radiologists, 4 endocrinologists) with varying experience levels and CNN, and 
AUS/FLUS subgroups were analyzed. Interobserver variability was assessed among the 8 physicians. 
Of the 202 nodules, 158 were AUS, and 44 were FLUS; 86 were benign, and 116 were malignant. 
The area under the curves (AUCs) of the 8 physicians and CNN were 0.680–0.722 and 0.666, without 
significant differences (P > 0.05). In the subgroup analysis, the AUCs for the 8 physicians and CNN 
were 0.657–0.768 and 0.652 for AUS, 0.469–0.674 and 0.622 for FLUS. Interobserver agreements 
were moderate (k = 0.543), substantial (k = 0.652), and moderate (k = 0.455) among the 8 physicians, 
4 radiologists, and 4 endocrinologists. For thyroid nodules with AUS/FLUS cytology, the diagnostic 
performance of CNN to differentiate malignancy with US images was comparable to that of physicians 
with variable experience levels.
Thyroid nodules occur commonly with incidence rates going up to 68%1, and ultrasonography (US) is the pri-
mary screening method used to detect these nodules with high sensitivity and specificity. Fine-needle aspiration 
(FNA) is an easy, relatively safe, and highly accurate diagnostic tool that can be performed under US-guidance 
to identify benign and malignant nodules based on US findings.
The Bethesda system is a standardized, category-based reporting system for thyroid cytopathology, and 
widely used to interpret FNA  results2. The nodules with Bethesda class III lesions, otherwise known as atypia of 
undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS), have a malignancy 
risk of 6–18%, and management plans vary widely from clinical observation, US follow up, repeat FNA or core 
needle biopsy, molecular test to thyroid  surgery2,3. Although thyroid US examination has been shown to help 
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stratify the risk of Bethesda class III  lesions3,4, US assessment is limited in application due to its inherent limita-
tions of poorly reproducible  tests5.
Recently, machine learning and deep learning methods have been developed, and have rapidly become the 
methodology of choice for medical image  analysis6,7. The deep convolutional neural network (CNN) is trained 
with an automated process using raw image pixels rather than engineered features extracted by experts of the 
traditional machine learning  algorithm7. For thyroid cancer diagnosis, many machine learning and deep learn-
ing techniques have been  implemented8–12. When machine learning techniques using support vector machines 
were compared with an experienced radiologist, they showed lower  accuracy13, while deep learning techniques 
showed similar accuracies to experienced radiologists and higher accuracies than inexperienced  radiologists12,14. 
Recently, we developed a computer-aided program that uses a deep convolutional neural network (CNN) to diag-
nose thyroid nodules according to US  features14. This CNN can be an objective, operator-independent method 
to identify benign lesions and malignancy, and these advantages are thought to be especially helpful for nodules 
with AUS/FLUS cytology on FNA in predicting malignant risk and determining the next management step.
The purpose of this study was to compare the diagnostic performances of physicians with varying experience 
levels and CNN to predict malignancy using US images of thyroid nodules with Bethesda class III results on FNA.
Results
Table 1 summarized the demographic features of the included 202 nodules. There were 86 (42.6%) benign 
nodules and 116 (57.4%) malignancies confirmed after surgery. The pathologic results after surgery were shown 
in Table 2. Of 202 nodules, preoperative FNA found 158 with AUS cytology and 44 with FLUS cytology. There 
was no statistical difference between the benign and malignant nodules for sex and age. Malignant nodules had 
significantly smaller size than benign ones (P = 0.009), and higher cancer probabilities than benign nodules 
using CNN (P < 0.001).
The diagnostic performances of the 8 physicians and CNN were compared in Table 3. The sensitivity, specific-
ity, and AUC of the 8 physicians were 24.1–50.9%, 81.4–98.8%, and 0.680–0.722, respectively (Table 3, Fig. 1). The 
calculated sensitivity, specificity, and AUC of CNN were 59.5%, 69.8%, and 0.666, respectively, using an estimated 
cut-off value of 54.1% (Table 3, Fig. 1). CNN showed significantly higher sensitivity than 6 physicians, but not 
over Radiologist 4 (50.0%; P = 0.082) and Endocrinologist 1 (50.9%; P = 0.137). CNN showed significantly lower 
specificity than all 8 physicians (P < 0.05). CNN had similar AUC values compared to the 8 physicians, without 
statistical difference (P > 0.05).
In the 158 nodules of the AUS group, the sensitivity, specificity, and AUC of the 8 physicians ranged 
25.0–52.8%, 76.0–98.0%, and 0.657–0.768, respectively, while the sensitivity, specificity, and AUC value of CNN 
was 62.0%, 66.0%, and 0.652 with a cut-off value of 54.1% (Table 3, Fig. 1). CNN showed significantly higher 
sensitivity than 6 physicians (ranges, 25.0–50.0%; P < 0.05) but not over Radiologist 4 (52.8%; P = 0.110) and 
Endocrinologist 1 (52.8%; P = 0.128). CNN showed significantly lower specificity than 7 physicians (ranges, 
82.0–98.0%; P < 0.050), but not lower than Endocrinologist 1 (76.0%; P = 0.123), and CNN had relatively lower 
AUC values than all 8 physicians, but this difference was only significant in Radiologist 2 (P = 0.011).
In the 44 nodules of the FLUS group, the sensitivity, specificity, and AUC of the 8 physicians were 0–25.0%, 
88.9–100%, and 0.469–0.674, respectively. The sensitivity, specificity, and AUC value of CNN was 62.5%, 77.8%, 
and 0.622, respectively, with an estimated cut-off value of 15.9% (Table 3, Fig. 1). CNN showed significantly 
Table 1.  Summary of the demographic features. AUS atypia of undetermined significance, FLUS follicular 
lesion of undetermined significance, IQR interquartile range, CNN deep convolutional neural network. a The 
independent two sample t-test. b We collected consecutive patients from three institutions, and the numbers of 
patients recruited from each hospital was expressed as Institution A, B, and C. c The Mann–Whitney U test.
Total Benign Malignancy P value
Numbers of nodules 202 86 (42.6%) 116 (57.4%)
Sex 0.416
Male 48 18 (20.9%) 30 (25.9%)
Female 154 68 (79.1%) 86 (74.1%)
Mean age (years)a 47.9 ± 13.3 47.0 ± 14.8 0.669









Institution  Bb 43 14 29









Institution  Bb 1 1 0
Institution  Cb 9 6 3
Median size (IQR, mm)c 19.5 (13–32) 13.5 (11–23) 0.009
Median cancer probability calculated by CNN (IQR, %)c 36.5 (18.7–69.5) 67.7 (30.2–89.9)  < 0.001
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Table 2.  Pathologic results after surgery. Data in parentheses are percentages. AUS atypia of undetermined 
significance, FLUS follicular lesion of undermined significance.
Pathologic result AUS FLUS Total
Benign
Adenomatous hyperplasia 22 (44.0) 12 (3.3) 34 (39.5)
Follicular adenoma 19 (38.0) 20 (55.6) 39 (45.3)
Hurthle cell adenoma 3 (6.0) 3 (8.3) 6 (7.0)
Noninvasive follicular thyroid neoplasm with papillary-like nuclear feature 3 (6.0) 1 (2.8) 4 (4.7)
Hyaline trabecular tumor 1 (2.0) – 1 (1.2)
Localized fibrosis 1 (2.0) – 1 (1.2)
Lymphocytic thyroiditis 1 (2.0) – 1 (1.2)
Total 50 36 86
Malignancy
Papillary thyroid carcinoma 99 (91.7) 4 (50.0) 103 (88.8)
Follicular carcinoma 8 (7.4) 3 (37.5) 11 (9.5)
Poorly differentiated carcinoma 1 (0.9) 1 (12.5) 2 (1.7)
Total 108 8 116
Table 3.  Diagnostic performances of the 8 physicians and deep convolutional neural network. R radiologist, 
E endocrinologist, CNN deep convolutional neural network, AUS atypia of undetermined significance, FLUS 
follicular lesion of undetermined significance. a Compared with the results of the convolutional neural network 
(CNN) using by generalized estimating equation. b Compared with the results of the CNN using by DeLong’s 
test.
Sensitivity P  valuea Specificity P  valuea AUC P  valueb
Total 202 nodules
R1 37.9% (29.1–46.8%)  < 0.001 96.5% (92.6–100%)  < 0.001 0.709 (0.643–0.776) 0.279
R2 44.8% (35.8–53.9%) 0.008 95.3% (90.9–99.8%)  < 0.001 0.717 (0.649–0.784) 0.187
R3 47.4% (38.3–56.5%) 0.020 89.5% (83.1–96.0%)  < 0.001 0.688 (0.62–0.757) 0.568
R4 50.0% (40.9–59.1%) 0.082 90.7% (84.6–96.8%)  < 0.001 0.722 (0.654–0.789) 0.145
E1 50.9% (41.8–60.0%) 0.137 81.4% (73.3–89.6%) 0.015 0.680 (0.612–0.749) 0.742
E2 39.7% (30.8–48.6%) 0.001 89.5% (83.1–96.0%) 0.001 0.695 (0.629–0.760) 0.500
E3 24.1% (16.4–31.9%)  < 0.001 98.8% (96.6–100%)  < 0.001 0.709 (0.642–0.775) 0.305
E4 42.2% (33.3–51.2%) 0.001 87.2% (80.2–94.3%) 0.002 0.692 (0.624–0.761) 0.494
CNN 59.5% (50.5–68.4%) 69.8% (60.1–79.5%) 0.666 (0.592–0.740)
AUS (n = 158)
R1 39.8% (30.6–49.0%)  < 0.001 96.0% (90.6–100%)  < 0.001 0.732 (0.658–0.806) 0.111
R2 47.2% (37.8–56.6%) 0.011 98.0% (94.2–100%)  < 0.001 0.768 (0.699–0.837) 0.011
R3 50.0% (40.6–59.4%) 0.029 86.0% (76.4–95.6%) 0.008 0.698 (0.618–0.778) 0.336
R4 52.8% (43.4–62.2%) 0.110 84.0% (73.8–94.2%) 0.008 0.705 (0.624–0.786) 0.253
E1 52.8% (43.4–62.2%) 0.128 76.0% (64.2–87.8%) 0.123 0.657 (0.574–0.741) 0.913
E2 42.6% (33.3–51.9%) 0.001 86.0% (76.4–95.6%) 0.008 0.685 (0.605–0.765) 0.525
E3 25.0% (16.8–33.2%)  < 0.001 98.0% (94.2–100%)  < 0.001 0.730 (0.654–0.806) 0.110
E4 44.4% (35.1–53.8%) 0.002 82.0% (71.4–92.6%) 0.037 0.675 (0.59–0.759) 0.628
CNN 62.0% (52.9–71.2%) 66.0% (52.9–79.1%) 0.652 (0.563–0.741)
FLUS (n = 44)
R1 12.5% (0–35.4%) 0.046 97.2% (91.9–100%) 0.011 0.469 (0.234–0.703) 0.435
R2 12.5% (0–35.4%) 0.046 91.7% (82.6–100%) 0.119 0.634 (0.372–0.895) 0.902
R3 12.5% (0–35.4%) 0.046 94.4% (87.0–100%) 0.046 0.535 (0.313–0.757) 0.493
R4 12.5% (0–35.4%) 0.046 100% (100–100%) 0.001 0.535 (0.290–0.780) 0.699
E1 25.0% (0–55.0%) 0.128 88.9% (78.6–99.2%) 0.239 0.587 (0.371–0.803) 0.857
E2 0% (0–0%) 0.001 94.4% (87.0–100%) 0.046 0.509 (0.320–0.697) 0.528
E3 12.5% (0–35.4%) 0.046 100% (100–100%) 0.001 0.674 (0.465–0.882) 0.803
E4 12.5% (0–35.4%) 0.046 94.4% (87.0–100%) 0.046 0.615 (0.420–0.809) 0.970
CNN 62.5% (29.0–96.0%) 77.8% (64.2–91.4%) 0.808 0.622 (0.355–0.888)
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higher sensitivity than 7 physicians (ranges, 0–12.5%; P < 0.050) but not over Endocrinologist 1 (25.0%; P = 0.128). 
CNN showed significantly lower specificity than 6 physicians (P < 0.050) but not lower than Radiologist 2 (91.7%, 
P = 0.119) and Endocrinologist 1 (88.9%, P = 0.239). AUC values did not differ between the 8 physicians and 
CNN (P > 0.050).
For interobserver variability, the 8 physicians showed moderate agreement (k = 0.543; 95% confidence inter-
val [CI], 0.381–0.414), the 4 radiologists substantial agreement (k = 0.652; 95% CI, 0.596–0.709), and the 4 
endocrinologists moderate agreement (k = 0.455; 95% CI, 0.399–0.511). In the subgroup analysis for the 158 
nodules with AUS cytology, the 8 physicians showed moderate agreement (k = 0.523; 95% CI, 0.493–0.552), the 4 
radiologists substantial agreement (k = 0.624; 95% CI, 0.560–0.687), and the 4 endocrinologists moderate agree-
ment (k = 0.447; 95% CI, 0.383–0.511). The 8 physicians showed fair agreement (k = 0.349; 95% CI, 0.293–0.405), 
substantial agreement (k = 0.647; 95% CI, 0.526–0.767), and slight agreement (k = 0.106; 95% CI, 0.015–0.226) 
for the 44 nodules with FLUS cytology.
Discussion
The AUS/FLUS cytology includes a heterogeneous and broad spectrum of diagnoses which contain more pro-
nounced cells with architectural and/or nuclear atypia than benign lesions but not enough of these cells to be 
considered malignant, and have a malignancy risk of 6–18% after NIFTP is removed which can make it difficult 
for clinicians to reach a decision on further  management2. For nodules of this category, we can perform repeat 
Figure 1.  Comparing diagnostic performances between the 8 physicians and CNN using the receiver operating 
characteristic analysis for the atypia of undetermined significance (AUS)/follicular lesion of undetermined 
significance (FLUS, A), only AUS (B), and only FLUS (C) groups. Data in parentheses are the AUC results of 
each physician or CNN. CNN deep convolutional neural network, AUS atypia of undetermined significance, 
FLUS follicular lesion of undetermined significance, R radiologist, E endocrinologist.
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FNA/CNB or molecular tests as supplementary evaluation methods instead of proceeding to surgery; however, 
even results from repeated FNA show the same cytology in 10–30% of the  nodules15. In nodules with AUS/FLUS 
cytology, US features can help stratify the malignancy risk of thyroid  nodules3,4,16–18. A meta-analysis study 
showed that the more suspicious US features a nodule has, the more likely it is to be  malignant3, with similar 
results being observed in nodules with AUS cytology, but not in those with FLUS  cytology16,17. However, the US 
examination itself is highly subjective, operator dependent and less reproducible than other imaging  methods5,19.
CNN is a typical deep learning algorithm based on feature  recognition9,20,21. It can extract regular features 
automatically from 2D images including thyroid US to achieve good diagnostic results; thus, CNN is more objec-
tive and highly reproducible compared to US when assisting  diagnosis20,22–25. Several recent studies have shown 
comparable diagnostic performance between radiologists and CNN for evaluating thyroid nodules on  US22–25. 
This study mainly aimed to suggest a possible supportive role of CNN for predicting malignancy in AUS/FLUS 
lesions. Past studies have compared the diagnostic performances of CNN and human physicians, but to our 
knowledge, all of the physicians in these past studies were  radiologists22,24–26. Our study compared the diagnostic 
performances of 8 physicians and CNN for diagnosing thyroid malignancy and the physicians in our study were 
a heterogeneous group of 4 radiologists and 4 endocrinologists with variable levels of experience.
Among the machine learning and deep learning methods newly developed,, CNN showed the highest accu-
racy and specificity to differentiate Bethesda category III nodules from Bethesda IV/V/VI nodules using US 
 images27. This previous study was performed to make decisions on treatment, but diagnostic accuracy was not 
compared between the clinician and the machine or deep learning approaches. In contrast, both radiologists and 
endocrinologists with varying levels of experience performed US analyses in our study to predict malignancy in 
thyroid nodules with AUS/FLUS cytology. We found the AUC of CNN to be similar to those of the 8 physicians 
for diagnosing malignancy. CNN showed higher sensitivity and lower specificity for diagnosing malignancy in 
AUS/FLUS lesions than the 8 physicians and these results were comparable to those of other recent studies with 
higher sensitivity and lower specificity for CNN compared to  radiologists13,22,25,26. However, our results for both 
CNN and radiologists showed relatively lower sensitivity, higher specificity, and lower AUC values than other 
 studies22,25,26. Our study only included nodules with AUS/FLUS confirmed at FNA. Furthermore, the structures 
of CNNs are varying in each study and used cut-off values to make the decision based on the probability results 
from CNNs (there are diverse approaches to determine the cut-off value) are different. In comparison, other 
studies included thyroid nodules without considering their cytologic results of FNA. Thus, the absolute values 
of the diagnostic performances are affected by these differences. Rather than weighing the absolute values of the 
diagnostic performances, it would be more appropriate to check and compare trends. Moreover, most of our 
study population consisted of AUS nodules (78.2%), and CNN also showed similar diagnostic performances 
with AUS/FLUS.
Interobserver variability is a very important issue because US is highly subjective and operator dependent as 
mentioned above, and diagnosis using captured JPEG images is more  subjective5,19. There was a study evaluating 
the interobserver variability of three radiologists with various experience levels (a resident, a fellow, and a staff), 
and moderate agreement was observed for each US characteristic (k = 0.473–0.634) except for shape (k = 0.034)26. 
Ko et al. reported fair interobserver variability between two radiologists using TI-RADS by Kwak et al., and 
criteria by Kim et al.25. We only analyzed risk levels according to the ACR TI-RADS system for interobserver 
variability, and did not analyze each US feature. Our results showed moderate interobserver variability among 
the 8 physicians. Substantial agreement was observed between the 4 radiologists, which is slightly superior 
to the interobserver variability of all 8 physicians and also the interobserver variability of 4 endocrinologists. 
Our 4 radiologists had different levels of experience with thyroid US, but their daily work exposed them much 
more to US images, making them also much more familiar with US images and the ACR TI-RADS system than 
endocrinologists.
Our study has several limitations. First, there was selection bias due to its retrospective study design. Second, 
the total sample size was not large despite it being a multicenter study, and the number of FLUS cytology nodules 
was only 44 (21.8%), which is relatively small for generalizing its findings to an entire population. Third, the 
malignancy rate after surgery was 57.4%, much higher than the rate recommended by the Bethesda  system2. 
For AUS/FLUS cytology, excision can be considered when repeated FNA/CNB or molecular tests are not help-
ful or nodules show suspicious US characteristics. We used the inclusion criteria of surgery-performed lesions 
only, thus, a higher malignancy rate is expected. Fourth, we only compared the risk levels of the ACR TI-RADS 
system without considering each US feature, which again was a point of conflict between the 8 physicians (Sup-
plementary Table 1).
The diagnostic performance of CNN was comparable to that of physicians with variable experience levels in 
differentiating malignancy from thyroid nodules with AUS/FLUS cytology on US.
Methods
This multicenter study was based on patient data collected from three tertiary referral institutions in South 
Korea. The institutional review boards (IRB) of all three institutions approved this retrospective observational 
study and the need of informed consent was waived for the review of patient images and records by three IRBs 
(Kangbuk Samsung Hospital Institutional Review Board, 2020-03-020; Yonsei University Health System, Sever-
ance Hospital, Institutional Review Board, 4-2020-0106; and Seoul National University College of Medicine/ 
Seoul National University Hospital Institutional Review Board, 1911-039-1076). This study was performed in 
accordance with relevant guidelines and regulations.
We collected 3,590 consecutive patients who underwent thyroid surgery at each hospital (Institution A, Jan 
2014 to Jun 2019, n = 1938; Institution B, Jan 2019 to Sep 2019, n = 1311; and Institution C, Jan 2017 to Jun 2019, 
n = 341; Fig. 2). In these patients, we searched for nodules ≥ 1 cm that were confirmed as Bethesda category III 
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on FNA and surgically excised. Finally, 202 nodules in 202 patients were included in this study (A, n = 112; B, 
n = 44; and C, n = 46; Fig. 2).
US examinations and imaging interpretation. US examinations were performed using several types 
of US machines (Supplementary Information 1). One clinician at each hospital reviewed the preoperative thy-
roid US images, selected the most representative image of each thyroid nodule, and saved them as JPEG files 
(Fig. 3). A square region-of-interest (ROI) was then drawn to cover each whole nodule using the Microsoft Paint 
program (version 6.1; Microsoft Corporation, Redmond, WA, USA). The saved images from the 3 hospitals were 
randomly mixed and numbered by an experienced radiologist (Fig. 3). They were independently reviewed by the 
following 8 physicians, none who had information on the cytopathologic results of each thyroid nodule: 2 faculty 
radiologists (7 and 10 years of experience in thyroid imaging), 2 less experienced radiologists (2 and 4 years of 
experience), 2 faculty endocrinologists (more than 5 years of experience), and 2 less experienced endocrinolo-
gists (1 year of experience). Before reviewing the captured images, all of 8 physicians were trained using the 
user’s guide by ACR TI-RADS28.
The 8 physicians evaluated the following US features using the TI-RADS system proposed by the ACR 28: 
composition (cystic or almost completely cystic, spongiform, mixed cystic and solid, solid or almost completely 
solid), echogenicity (anechoic, hyperechoic or isoechoic, hypoechoic, very hypoechoic), shape (wider-than-taller, 
taller-than-wide), margin (smooth, ill-defined, lobulated or irregular, extrathyroidal extension), and echogenic 
foci (none or large comet-tail artifacts, macrocalcifications, peripheral calcifications, punctate echogenic foci). 
Eight physicians determined malignancy risk using the ACR TI-RADS system and the assigned risk levels ranged 
from TI-RADS (TR) 1 (benign, 0 points), TR2 (not suspicious, 2 points), TR3 (mildly suspicious, 3 points), TR4 
(moderately suspicious, 4–6 points), to TR5 (highly suspicious, 7 or more points) (Supplementary Table 2)28.
Deep convolutional neural network. In this study, we used a computer-aided diagnosis (CAD) program 
to differentiate malignancy from benign lesions, which was recently developed with 13,560 US images of thy-
roid nodules using a deep convolutional neural  network14. The CAD program was based on a transfer learning 
technique equipped with fine-tuning in order to overcome the limited amount of data and maximize accuracy 
Figure 2.  Diagram of the study group which included patients from 3 different hospitals. FNA fine-needle 
aspiration, AUS atypia of undetermined significance, FLUS follicular lesion of undetermined significance.
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through a combination of big data and deep learning. Four sophisticated pre-trained nets (AlexNet, SqueezeNet, 
GoogLeNet, and Inception-ResNet-v2) were used and a weighted average process was performed (see Supple-
mentary Information 2 and Supplementary Fig. 1 for details on the averaging process). To train the networks 
with the fine-tuning process, the stochastic gradient descent method with momentum was used as a solver, and 
various parameter values (initial learning rate, learning rate dropping periods, max epochs, mini-batch sizes, 
etc.) were chosen through a selection process including Bayesian optimization.
Statistical analysis. We collected data on the final diagnosis of each thyroid nodule after surgery that had 
been recorded in the electronic medical records of each hospital. Cancer probabilities were calculated using 
CNN, and were presented as percentages (0–100%). Categorical data were summarized as frequencies and 
percentages, and continuous variables were presented as means ± standard deviations or median (interquartile 
range). The Shapiro–Wilk test was performed to assess the normality of continuous variables. We evaluated dif-
ferences in variables using the independent two-sample t-test, Mann–Whitney U test, Chi-square test, or Fisher’s 
exact test.
Sensitivities and specificities of the 8 physicians and CNN for predicting malignancy were evaluated and 
compared by generalized estimating equation (GEE). Of the risk levels of the ACR TI-RADS system, we used 
a cut-off point of TR 5 for the 8 physicians. The cut-off values of CNN were determined with Youden’s index. 
A receiver operating characteristic (ROC) curve analysis and areas under the curve (AUCs) were compared by 
DeLong’s test. The diagnostic performances of the 8 physicians and CNN were evaluated in each AUS and FLUS 
group, and also compared using the ROC curve analysis.
We evaluated interobserver variability among all 8 physicians using Fleiss’ Kappa, and then divided the 
physicians into 2 groups to also compare interobserver variability among the 4 radiologists and among the 4 
endocrinologists separately with Fleiss’ Kappa. A kappa value (k) of less than 0 indicated no agreement; 0–0.20, 
slight agreement; 0.21–0.40, fair agreement; 0.41–0.60, moderate agreement; 0.61–0.80, substantial agreement; 
and 0.81–1.00, almost perfect  agreement29.
All P values were calculated using the two-tailed t-test and a P < 0.05 was considered to indicate statistical 
significance. All statistical analyses were performed using SAS software, version 9.4 (SAS Institute, Inc., Cary, 
NC, USA) and R Core Team (2020) (R: A language and environment for statistical computing. R Foundation 
for Statistical Computing, Vienna, Austria. URL https:// www.R- proje ct. org/).
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